150 related articles for article (PubMed ID: 35430796)
1. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study.
Zhao Z; Zhang T; Yao Y; Lu X
BMC Surg; 2022 Apr; 22(1):143. PubMed ID: 35430796
[TBL] [Abstract][Full Text] [Related]
2. Reconceptualizing the clinicopathological features, locoregional therapy and prognostic factors of occult breast cancer in the era of molecular subtyping.
Ye X; Yang L; He Q; Lin X; Wang J; Cui R; Xu C
Women Health; 2023 Feb; 63(2):105-114. PubMed ID: 36576239
[TBL] [Abstract][Full Text] [Related]
3. Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study.
Ge LP; Liu XY; Xiao Y; Gou ZC; Zhao S; Jiang YZ; Di GH
Cancer Manag Res; 2018; 10():4381-4391. PubMed ID: 30349371
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of optimal surgical management for occult breast carcinoma: Mastectomy or quadrantectomy?
Huang Y; Wu H; Luo Z
Medicine (Baltimore); 2017 Dec; 96(52):e9490. PubMed ID: 29384945
[TBL] [Abstract][Full Text] [Related]
6. Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based Stage-by-Stage Comparison.
Ye JC; Yan W; Christos PJ; Nori D; Ravi A
Clin Breast Cancer; 2015 Oct; 15(5):390-7. PubMed ID: 25957740
[TBL] [Abstract][Full Text] [Related]
7. Breast-conserving surgery is an appropriate procedure for centrally located breast cancer: a population-based retrospective cohort study.
Yuan YW; Liu PC; Li FF; Yang YH; Yang W; Fan L; Mou DW; Yang HW; Chen MS
BMC Surg; 2023 Oct; 23(1):298. PubMed ID: 37789365
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
Wan Q; Su L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
JAMA Netw Open; 2021 Apr; 4(4):e216259. PubMed ID: 33890992
[TBL] [Abstract][Full Text] [Related]
9. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.
Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH
J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883
[TBL] [Abstract][Full Text] [Related]
10. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
Li H; Chen Y; Wang X; Tang L; Guan X
Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327
[TBL] [Abstract][Full Text] [Related]
11. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients.
Zhang J; Yang C; Lei C; Zhang Y; Ji F; Gao H; Yang M; Zhang L; Li J; Zhu T; Li W; Zhuang X; Wang K
Breast; 2021 Aug; 58():10-17. PubMed ID: 33878598
[TBL] [Abstract][Full Text] [Related]
13. Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI.
Kim H; Park W; Kim SS; Ahn SJ; Kim YB; Kim TH; Kim JH; Choi JH; Park HJ; Chang JS; Choi DH
Breast; 2020 Feb; 49():63-69. PubMed ID: 31734590
[TBL] [Abstract][Full Text] [Related]
14. Breast-conserving therapy is associated with better survival than mastectomy in Early-stage breast cancer: A propensity score analysis.
Ji J; Yuan S; He J; Liu H; Yang L; He X
Cancer Med; 2022 Apr; 11(7):1646-1658. PubMed ID: 35212160
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors and a Model for Occult Breast Cancer: A Population-Based Cohort Study.
Zhang D; Zhai J; Li L; Wu Y; Ma F; Xu B
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431280
[TBL] [Abstract][Full Text] [Related]
16. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
[TBL] [Abstract][Full Text] [Related]
17. Oncoplastic breast conservation occupies a niche between standard breast conservation and mastectomy - A population-based prospective audit in Scotland.
Morrow ES; Stallard S; Doughty J; Malyon A; Barber M; Dixon JM; Romics L
Eur J Surg Oncol; 2019 Oct; 45(10):1806-1811. PubMed ID: 30902354
[TBL] [Abstract][Full Text] [Related]
18. Early-stage young breast cancer patients: impact of local treatment on survival.
Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer.
He M; Tang LC; Yu KD; Cao AY; Shen ZZ; Shao ZM; Di GH
Eur J Surg Oncol; 2012 Nov; 38(11):1022-8. PubMed ID: 22959166
[TBL] [Abstract][Full Text] [Related]
20. Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.
Lagendijk M; van Maaren MC; Saadatmand S; Strobbe LJA; Poortmans PMP; Koppert LB; Tilanus-Linthorst MMA; Siesling S
Int J Cancer; 2018 Jan; 142(1):165-175. PubMed ID: 28884470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]